Literature DB >> 3955481

Hepatitis B: update on perinatal management. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

.   

Abstract

Infants of women infected with hepatitis B virus (HBV) are at risk of acquiring hepatitis B, usually at the time of delivery but occasionally in utero or after delivery. Perinatally acquired HBV infections are noteworthy for their tendency to persist throughout life, predisposing victims to cirrhosis and hepatocellular carcinoma. In most instances perinatal infection can be prevented by combined passive-active immunization of infants at risk. It is recommended that attempts be made to identify pregnant women infected with HBV and that their infants be given hepatitis B immune globulin soon after birth, then be actively immunized with HBV vaccine. This approach is effective and safe and is subsidized in many provinces.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3955481      PMCID: PMC1490952     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  11 in total

1.  Breast-feeding by mothers positive for HBsAG.

Authors:  R P Larke; J C Haworth; J H Read
Journal:  Can Med Assoc J       Date:  1977-06-18       Impact factor: 8.262

2.  Safety of the hepatitis B vaccine.

Authors:  C E Stevens; P E Taylor; P Rubinstein; R C Ting; A J Bodner; M G Sarngadharan; R C Gallo
Journal:  N Engl J Med       Date:  1985-02-07       Impact factor: 91.245

3.  Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial.

Authors:  R P Beasley; L Y Hwang; C C Lin; C E Stevens; K Y Wang; T S Sun; F J Hsieh; W Szmuness
Journal:  Lancet       Date:  1981-08-22       Impact factor: 79.321

4.  Immune response to hepatitis B vaccine in newborns.

Authors:  O W Prozesky; C E Stevens; W Szmuness; H Rolka; E J Harley; M C Kew; J E Scholtz; A D Mitchell
Journal:  J Infect       Date:  1983-07       Impact factor: 6.072

5.  Hepatitis B virus and the prevention of primary hepatocellular carcinoma.

Authors:  B S Blumberg; W T London
Journal:  N Engl J Med       Date:  1981-03-26       Impact factor: 91.245

6.  HBsAg positive adopted children as a cause of intrafamilial spread of hepatitis B.

Authors:  E Nordenfelt; E Dahlquist
Journal:  Scand J Infect Dis       Date:  1978

7.  Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization.

Authors:  C E Stevens; P T Toy; M J Tong; P E Taylor; G N Vyas; P V Nair; M Gudavalli; S Krugman
Journal:  JAMA       Date:  1985 Mar 22-29       Impact factor: 56.272

8.  Postnatal infectivity of hepatitis B surface antigen-carrier mothers.

Authors:  R P Beasley; L Y Hwang
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

9.  Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine.

Authors:  R P Beasley; L Y Hwang; G C Lee; C C Lan; C H Roan; F Y Huang; C L Chen
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

10.  The newly licensed hepatitis B vaccine. Characteristics and indications for use.

Authors:  S Krugman
Journal:  JAMA       Date:  1982-04-09       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.